Link Pharma Chem Limited (BOM:524748)
India · Delayed Price · Currency is INR 27.00
-1.00 (-3.57%)
At close: Jun 1, 2026
Link Pharma Chem Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 0.77 | -10.27 | -13.63 | 6.54 | 18.82 |
Depreciation & Amortization | 9.8 | 9.43 | 10.34 | 9.23 | 9.28 |
Loss (Gain) From Sale of Assets | - | - | -0.79 | - | -1.18 |
Loss (Gain) From Sale of Investments | 0.88 | -1.25 | -4.94 | 2.61 | -2.19 |
Provision & Write-off of Bad Debts | 1.85 | 0.23 | 0.56 | 4.15 | 0.35 |
Other Operating Activities | 5.3 | 3.46 | -0.73 | 4.74 | 3.98 |
Change in Accounts Receivable | -4.48 | 1.11 | -15.77 | 13.2 | 1.52 |
Change in Inventory | 7.14 | 4.72 | 60.42 | -74.93 | -22.61 |
Change in Accounts Payable | 0.87 | 20.05 | -49.5 | 6.46 | -17.12 |
Change in Other Net Operating Assets | -0.66 | -0.62 | 13.77 | 10.94 | -3.43 |
Operating Cash Flow | 21.47 | 26.86 | -0.28 | -17.07 | -12.59 |
Operating Cash Flow Growth | -20.08% | - | - | - | - |
Capital Expenditures | -21 | -2.57 | -9.5 | -8.93 | -11.56 |
Sale of Property, Plant & Equipment | - | - | 1.2 | - | 4.11 |
Investment in Securities | -5.95 | 17.25 | 11.54 | 6.7 | -43.24 |
Other Investing Activities | 0.38 | 0.62 | 0.81 | 1.48 | 1.01 |
Investing Cash Flow | -26.57 | 15.29 | 4.05 | -0.75 | -49.67 |
Short-Term Debt Issued | 4.23 | - | 20.29 | 32.05 | 25.84 |
Long-Term Debt Issued | 15.03 | - | - | 5.3 | 10 |
Total Debt Issued | 19.26 | - | 20.29 | 37.35 | 35.84 |
Short-Term Debt Repaid | - | -26.95 | - | - | - |
Long-Term Debt Repaid | -4.04 | -7.44 | -15.64 | -13.66 | -8.61 |
Total Debt Repaid | -4.04 | -34.39 | -15.64 | -13.66 | -8.61 |
Net Debt Issued (Repaid) | 15.22 | -34.39 | 4.65 | 23.69 | 27.24 |
Other Financing Activities | -5.3 | -7.76 | -8.72 | -7.61 | -4.51 |
Financing Cash Flow | 9.92 | -42.15 | -4.07 | 16.08 | 22.72 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - |
Net Cash Flow | 4.81 | 0 | -0.3 | -1.74 | -39.54 |
Free Cash Flow | 0.47 | 24.29 | -9.78 | -26 | -24.15 |
Free Cash Flow Growth | -98.08% | - | - | - | - |
Free Cash Flow Margin | 0.17% | 9.55% | -3.27% | -6.71% | -4.51% |
Free Cash Flow Per Share | 0.10 | 5.47 | -2.20 | -5.86 | -5.44 |
Cash Interest Paid | - | 7.76 | 8.72 | 7.61 | 4.07 |
Cash Income Tax Paid | - | -0.34 | 3.7 | 4.06 | 6.75 |
Levered Free Cash Flow | -7.02 | 19.05 | -4.16 | -28.64 | -35.68 |
Unlevered Free Cash Flow | -3.71 | 23.9 | 1.29 | -23.89 | -32.86 |
Change in Working Capital | 2.87 | 25.26 | 8.91 | -44.33 | -41.64 |